To further examine the effect of MY11 on the NF-κB signaling pathway in breast cancer cells, we detected phosphorylated p65 using Western blot analysis and showed that p65 phosphorylation was effectively activated by MY11 treatment in a time-dependent manner (Fig. 4D). Here, NFKB1 is linked to breast carcinoma.